Skip to main content
. 2018 Jul 3;8:9999. doi: 10.1038/s41598-018-28325-w

Figure 5.

Figure 5

Anti-α-Gal antibody levels in cases (malaria) vs controls (no malaria). (A) Infants and children from both sites together. (B) Stratified by age group. (C) Stratified by site. Data correspond to samples collected at M3 (after the third vaccine dose and prior the 12 months of follow up) from children participants in the RTS,S phase 3 clinical trial. Cases were defined as children with at least one episode of clinical malaria during the 12 months of follow up. Boxplots represent the median and interquartile range. Groups were compared through t-tests and p-values were adjusted for multiple comparisons through Benjamini-Hochberg and Holm (in parenthesis). Infant: 1.5–3 months; Children: 5–17 months.